Henrich Jill
- SEC CIK
- 0001978096
No open-market purchases or sales filed in the past year.
Current role at each company
- ATRA Atara Biotherapeutics, Inc.EVP, Chief Regulatory Officeras of Mar 5, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Henrich Jill as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Henrich JillEVP, Chief Regulatory Officer | SSale | −1.06K | $7.00 | −$7.41K | −5.4%18.7K after | |
| Nov 20, 2024 (view filing) | Nov 18 | 2 days | Henrich JillEVP, Chief Regulatory Officer | SSale | −1.00K | $11.20 | −$11.2K | −4.9%19.4K after | |
| Aug 20, 2024 (view filing) | Aug 16 | 4 days | Henrich JillEVP, Global Head RA & Quality | SSale | −963 | $6.63 | −$6.38K | −4.5%20.4K after | 2 lots |
| May 20, 2024 (view filing) | May 16 | 4 days | Henrich JillEVP, Global Head RA & Quality | SSale | −25.8K | $0.62 | −$16.0K | −4.6%529.3K after | |
| Mar 6, 2024 (view filing) | Mar 4 | 2 days | Henrich JillEVP, Global Head RA & Quality | SSale | −3.88K | $0.72 | −$2.79K | −0.7%555.0K after | |
| Nov 20, 2023 (view filing)5:29 PM ET | Nov 16 | 4 days | Henrich JillEVP, Global Head RA & Quality | SSale | −3.27K | $0.389 | −$1.27K | −3.0%104.4K after | |
| Aug 18, 2023 (view filing) | Aug 16 | 2 days | Henrich JillEVP, Global Head RA & Quality | SSale | −3.35K | $1.65 | −$5.52K | −3.0%107.7K after | 2 lots |